Department of Neurology, Peking University First Hospital, Beijing 100034, PR China.
Department of Pediatrics, Peking University First Hospital, Beijing 100034, PR China.
J Neurol Sci. 2018 Feb 15;385:151-155. doi: 10.1016/j.jns.2017.12.033. Epub 2017 Dec 29.
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) is a common mitochondrial syndrome. The aim of this study was to conduct a survival analysis based on the clinical features of a Chinese MELAS patient cohort.
This is a retrospective single-center study. The MELAS patients were followed up for 1-8years (median 4years). The disease severity was evaluated by the modified Rankin Scale (mRS). The survival analysis was performed using Kaplan-Meier analysis and Cox proportional hazards model.
A total of 138 subjects were enrolled, and the median disease duration was 7years [interquartile range (IQR) 4-11years]. The stroke-like episodes were the most common initial symptoms (70.3%). Seventeen (17.3%) subjects lost to follow-up. Of the 121 subjects who successfully completed the follow-up, 28 subjects died (mortality rate 23.1%). An acute stroke-like episode and/or status epilepticus were the predominant causes of death (42.9%). Among the surviving patients (n=93), 39.8% (37/93) required assistance in daily life (mRS scores 3-5). The mRS scores were inversely correlated with the age of onset (r=-0.28, P=0.0022) but not with the disease duration (r=0.10, P=0.2709). The survival rate declined mainly within 12years after the disease onset. The stroke-like episode as the initial symptom was an independent risk factor for death (hazard ratio=2.86, 95% CI 1.03-7.94, P=0.043).
MELAS had high mortality and morbidity in this cohort of Chinese patients. The early onset of stroke-like episodes might indicate the more severe form of the disease, highlighting the importance of management of stroke-like episodes to improve the prognosis.
线粒体脑肌病伴高乳酸血症和卒中样发作(MELAS)是一种常见的线粒体综合征。本研究旨在基于中国 MELAS 患者队列的临床特征进行生存分析。
这是一项回顾性单中心研究。MELAS 患者的随访时间为 1-8 年(中位数 4 年)。采用改良 Rankin 量表(mRS)评估疾病严重程度。采用 Kaplan-Meier 分析和 Cox 比例风险模型进行生存分析。
共纳入 138 例患者,中位疾病病程为 7 年[四分位间距(IQR)4-11 年]。卒中样发作是最常见的首发症状(70.3%)。17 例(17.3%)患者失访。在 121 例成功完成随访的患者中,28 例死亡(死亡率 23.1%)。急性卒中样发作和/或癫痫持续状态是主要死亡原因(42.9%)。在幸存患者(n=93)中,39.8%(37/93)需要日常生活帮助(mRS 评分 3-5)。mRS 评分与发病年龄呈负相关(r=-0.28,P=0.0022),与病程无关(r=0.10,P=0.2709)。发病后 12 年内生存率下降主要与疾病发病有关。卒中样发作作为首发症状是死亡的独立危险因素(危险比=2.86,95%可信区间 1.03-7.94,P=0.043)。
本研究中中国患者队列 MELAS 死亡率和发病率较高。卒中样发作的早期发作可能提示疾病更为严重,突出了对卒中样发作进行管理以改善预后的重要性。